Gujarat Terce Laboratories バランスシートの健全性
財務の健全性 基準チェック /46
Gujarat Terce Laboratories has a total shareholder equity of ₹88.6M and total debt of ₹39.4M, which brings its debt-to-equity ratio to 44.5%. Its total assets and total liabilities are ₹248.4M and ₹159.8M respectively. Gujarat Terce Laboratories's EBIT is ₹32.2M making its interest coverage ratio 14.5. It has cash and short-term investments of ₹948.0K.
主要情報
44.5%
負債資本比率
₹39.43m
負債
| インタレスト・カバレッジ・レシオ | 14.5x |
| 現金 | ₹948.00k |
| エクイティ | ₹88.61m |
| 負債合計 | ₹159.78m |
| 総資産 | ₹248.39m |
財務の健全性に関する最新情報
更新なし
Recent updates
財務状況分析
短期負債: 524314's short term assets (₹131.3M) exceed its short term liabilities (₹106.4M).
長期負債: 524314's short term assets (₹131.3M) exceed its long term liabilities (₹53.4M).
デット・ツー・エクイティの歴史と分析
負債レベル: 524314's net debt to equity ratio (43.4%) is considered high.
負債の削減: 524314's debt to equity ratio has increased from 19.6% to 44.5% over the past 5 years.
債務返済能力: 524314's debt is well covered by operating cash flow (32.7%).
インタレストカバレッジ: 524314's interest payments on its debt are well covered by EBIT (14.5x coverage).